0001213900-21-028751 | 10-K/A | XBRL Viewer | Sustainable Opportunities Acquisition Corp

Print Document View Excel Document

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Dec. 31, 2020	Mar. 30, 2021	Jun. 30, 2020
Document Information Line Items
Entity Registrant Name	Sustainable Opportunities Acquisition Corp.
Document Type	10-K/A
Current Fiscal Year End Date	--12-31
Entity Public Float			$ 291,000,000
Amendment Flag	true
Amendment Description	Sustainable Opportunities Acquisition Corp. (the “Company”) is filing this Amendment No. 1 to its Annual Report for the fiscal year ended December 31, 2020 on Form 10-K/A (the “Amendment”) to amend and restate certain items in its Annual Report for the fiscal year ended December 31, 2020 on Form 10-K originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 30, 2021 (the “Original 10-K”). We are also restating our financial statements as of May 8, 2020, as of and for the year ended December 31, 2020, as of and for the three and nine month periods ended September 30, 2020 and as of and for the three and six month periods ended June 30, 2020 (the “Affected Periods”) in the accompanying financial statements included in this Annual Report, including describing the restatement and its impact on previously reported amounts.The restatement results from the Company’s prior accounting for its outstanding warrants issued in connection with its initial public offering in May 2020 as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of common stock, all holders of the warrants would be entitled to receive cash for their warrants (the “tender offer provision”). In other words, in the event of a qualifying cash tender offer (which could be outside the control of the Company), all warrant holders would be entitled to cash, while only certain of the holders of the underlying common stock would be entitled to cash.On April 12, 2021, the Staff of the SEC’s Division of Corporation Finance (“Staff”) issued a statement (the “Staff Statement”) entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies.” In the Staff Statement, the Staff, among other things, highlighted potential accounting implications of certain terms that are common in warrants issued in connection with the initial public offerings of special purpose acquisition companies such as the Company. As a result of the Staff Statement and in light of evolving views as to certain provisions commonly included in warrants issued by special purpose acquisition companies, the Company re-evaluated its accounting for its public warrants and private placement warrants issued in connection with the Company’s initial public offering (the “Warrants”), and concluded that the Warrants should be treated as derivative liabilities pursuant to Accounting Standards Codification (“ASC”) Subtopic 815-40 rather than as components of equity as the Company previously treated the Warrants.As a result of the above, the Company should have classified its Warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the Warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. Therefore, the Company is restating in this Amendment its financial statements for the Affected Periods (the “Restatement”).In connection with the Restatement, the Company’s management reassessed the effectiveness of its disclosure controls and procedures for the Affected Periods. As a result of that reassessment, the Company’s management determined that its disclosure controls and procedures for the Affected Periods were not effective solely as a result of its classification of the Warrants as a component of equity instead of as derivative liabilities. For more information, see Part II, Item 9A, Controls and Procedures included in this Amendment.The Company has not amended its previously filed Current Report on Form 8-K or Quarterly Reports on Form 10-Q for the periods affected by the restatement. The financial information that has been previously filed or otherwise reported for these periods is superseded by the information in this Annual Report on Form 10-K/A, and the financial statements and related financial information contained in such previously filed reports should no longer be relied upon.The following items are amended in this Amendment: (i) Part I, Item 1A. Risk Factors; (ii) Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations; (iii) Part II, Item 8. Financial Statements and Supplementary Data; (iv) Part II, Item 9A. Controls and Procedures; and (v) Part IV, Item 15. Exhibits, Financial Statement Schedules (including to correct the hyperlinks to certain exhibits contained therein that contained errors in the Original 10-K due to a printer error). Additionally, in accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended, the Company is including with this Amendment currently dated certifications from our principal executive officer and principal financial officer. These certifications are filed or furnished, as applicable, as Exhibits 31.1, 31.2, 32.1 and 32.2.Except as described above, this Amendment does not amend, update or change any other disclosures in the Original 10-K. In addition, the information contained in this Amendment does not reflect events occurring after the filing of the Original 10-K and does not modify or update the disclosures therein, except as specifically identified above. Among other things, forward-looking statements made in the Original 10-K have not been revised to reflect events, results or developments that occurred or facts that became known to us after the date of the Original 10-K, other than the Restatement, and such forward-looking statements should be read in conjunction with our filings with the SEC, including those subsequent to the filing of the Original 10-K.
Entity Central Index Key	0001798562
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Entity File Number	001-39281
Entity Incorporation, State or Country Code	E9
Entity Interactive Data Current	Yes
Class A ordinary shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		30,000,000
Class B ordinary shares
Document Information Line Items
Entity Common Stock, Shares Outstanding		7,500,000

Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash	$ 1,299,301
Prepaid expenses	209,784	15,961
Total current assets	1,509,085	15,961
Investments held in Trust Account	300,069,135
Deferred offering costs associated with initial public offering		103,660
Total Assets	301,578,220	119,621
Current liabilities:
Accounts payable	34,298	23,060
Accrued expenses	1,846,704	80,600
Total current liabilities	1,881,002	103,660
Long term liabilities:
Warrant Liability	56,930,000
Deferred underwriting commissions	10,500,000
Total liabilities	69,311,002	103,660
Commitments and Contingencies (Note 6)
Class A ordinary shares, $0.0001 par value; 22,726,721 and -0- shares subject to possible redemption at $10.00 per share at December 31, 2020 and December 31, 2019, respectively	227,267,210
Shareholders’ Equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Class A ordinary shares, $0.0001 par value; 300,000,000 shares authorized; 7,273,279 and -0- shares issued and outstanding (excluding 22,726,721 and -0- shares subject to possible redemption) at December 31, 2020 and December 31, 2019, respectively	727
Class B ordinary shares, $0.0001 par value; 30,000,000 shares authorized; 7,500,000 shares issued and outstanding at December 31, 2020 and 8,625,000 shares issued and outstanding at December 31, 2019, respectively	750	863
Additional paid-in capital	41,549,625	24,137
Accumulated deficit	(36,551,094)	(9,039)
Total shareholders’ equity	5,000,008	15,961
Total Liabilities and Shareholders’ Equity	$ 301,578,220	$ 119,621

Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2020	Dec. 31, 2019
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Class A ordinary shares
Class A ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Class A ordinary shares, redemption per share (in Dollars per share)	$ 10.00	$ 10.00
Class A ordinary shares, redemption shares	22,726,721	0
Ordinary stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary stock, shares authorized	300,000,000	300,000,000
Ordinary stock, shares issued	7,273,279	0
Ordinary stock, shares outstanding	7,273,279	0
Class B ordinary shares
Ordinary stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary stock, shares authorized	30,000,000	30,000,000
Ordinary stock, shares issued	7,500,000	8,625,000
Ordinary stock, shares outstanding	7,500,000	8,625,000

Statements of Operations - USD ($)		12 Months Ended
Statements of Operations - USD ($)	Dec. 31, 2019	Dec. 31, 2020
Income Statement [Abstract]
General and administrative expenses	$ 9,039	$ 2,923,654
General and administrative expenses - related party		80,000
Loss from operations	(9,039)	(3,003,654)
Change in fair value of the warrant liability		(32,730,000)
Offering costs allocated to derivative warrant liabilities		(877,647)
Net gain on investments held in Trust Account		69,135
Interest earned		111
Net loss	$ (9,039)	$ (36,542,055)
Weighted average shares outstanding subject to possible redemption, basic and diluted (in Shares)		25,440,915
Basic and diluted net income per share, shares subject to possible redemption (in Dollars per share)		$ 0.00
Weighted average ordinary shares outstanding, basic and diluted (in Shares)	8,625,000	10,464,651
Basic and diluted net loss per share, Non-redeemable shares (in Dollars per share)	$ 0.00	$ (3.50)

Statements of Changes in Shareholders’ Equity - USD ($)	Class A ordinary shares	Class B ordinary shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 17, 2019
Balance (in Shares) at Dec. 17, 2019
Issuance of Class B ordinary shares to Sponsor		$ 863	24,137		25,000
Issuance of Class B ordinary shares to Sponsor (in Shares)		8,625,000
Net loss				(9,039)	(9,039)
Balance at Dec. 31, 2019		$ 863	24,137	(9,039)	15,961
Balance (in Shares) at Dec. 31, 2019		8,625,000
Balance at Dec. 31, 2019		$ 863	24,137	(9,039)	15,961
Balance (in Shares) at Dec. 31, 2019		8,625,000
Balance at Dec. 31, 2019		$ 863	24,137	(9,039)	15,961
Balance (in Shares) at Dec. 31, 2019		8,625,000
Sale of units in initial public offering, less fair value of Public Warrant	$ 3,000		285,297,000		285,300,000
Sale of units in initial public offering, less fair value of Public Warrant (in Shares)	30,000,000
Forfeiture of Class B ordinary shares		$ (113)	113
Forfeiture of Class B ordinary shares (in Shares)		(1,125,000)
Offering costs			(16,506,688)		(16,506,688)
Ordinary shares subject to possible redemption	$ (2,273)		(227,264,937)		(227,267,210)
Ordinary shares subject to possible redemption (in Shares)	(22,726,721)
Net loss				(36,542,055)	(36,542,055)
Balance at Dec. 31, 2020	$ 727	$ 750	$ 41,549,624	$ (36,551,094)	$ 5,000,008
Balance (in Shares) at Dec. 31, 2020	7,273,279	7,500,000

Statements of Cash Flows - USD ($)		12 Months Ended
Statements of Cash Flows - USD ($)	Dec. 31, 2019	Dec. 31, 2020
Cash Flows from Operating Activities:
Net loss	$ (9,039)	$ (36,542,055)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative warrant liability		32,730,000
Offering costs allocated to derivative warrant liabilities		877,647
General and administrative expenses paid by related party under note agreement	9,039	70,123
Net gain on investments held in Trust Account		(69,135)
Changes in operating assets and liabilities:
Prepaid expenses		(197,094)
Accounts payable		(51,821)
Accrued expenses		1,846,704
Net cash used in operating activities		(1,335,631)
Cash Flows from Investing Activities
Cash deposited in Trust Account		(300,000,000)
Net cash used in investing activities		(300,000,000)
Cash Flows from Financing Activities:
Proceeds received from initial public offering, gross		300,000,000
Proceeds from private placement		9,500,000
Offering costs paid		(6,702,089)
Repayment of note payable from related party		(162,979)
Net cash provided by financing activities		302,634,932
Net change in cash		1,299,301
Cash - beginning of the period
Cash - end of the period		1,299,301
Supplemental disclosure of noncash investing and financing activities:
Offering costs included in accounts payable	23,060	85,000
Offering costs included in accrued expenses	80,600
Offering costs funded with note payable to Sponsor		92,856
Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares to Sponsor	15,961
Use of retainer for offering costs		3,271
Deferred underwriting commissions in connection with the initial public offering		10,500,000
Initial value of Class A ordinary shares subject to possible redemption		262,826,540
Change in value of Class A ordinary shares subject to possible redemption		$ (35,559,330)

Description of Organization and Business Operations

12 Months Ended

Dec. 31, 2020

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Description of Organization and Business Operations

Note 1 — Description of Organization and Business Operations

Sustainable Opportunities Acquisition Corp. (the “Company”) is a newly organized blank check company incorporated as a Cayman Islands exempted company on December 18, 2019. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

As of December 31, 2020, the Company had not commenced any operations. All activity for the period from December 18, 2019 (inception) through December 31, 2020 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and, since the closing of the Initial Public Offering, a search for a business combination candidate. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on cash from the proceeds derived from the Initial Public Offering and interest income earned on investments held in Trust Account.

Sponsor, Initial Public Offering and Private Placement

The Company’s sponsor is Sustainable Opportunities Holdings LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on May 5, 2020. On May 8, 2020, the Company consummated its Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.4 million, inclusive of $10.5 million in deferred underwriting commissions (Note 6).

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 9,500,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $9.5 million (Note 5).

Trust Account

Upon the closing of the Initial Public Offering and the Private Placement, $300.0 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement were placed in a trust account (the “Trust Account”), located in the United States at JP Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

Initial Business Combination

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”).

The Company will provide the holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001 per share sold in the Initial Public Offering (the “Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 6). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association, which the Company adopted upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”) conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the Initial Shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.

Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.

The Company’s Sponsor, officers and directors (the “Initial Shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide holders of its Public Shares the right to have their shares redeemed in connection with its initial business combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 18 months from the closing of the Initial Public Offering, or November 8, 2021 (the “Combination Period”) unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

If the Company is unable to complete a Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay for its tax obligations, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

The Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriter has agreed to waive its rights to its deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Proposed Business Combination

On March 4, 2021, the Company entered into a Business Combination Agreement (the “Business Combination Agreement”), by and among the Company, 1291924 B.C. Unlimited Liability Company, an unlimited liability company existing under the laws of British Columbia, Canada (“NewCo Sub”), and DeepGreen Metals Inc., a company existing under the laws of British Columbia, Canada (the “Company” or “DeepGreen”).

Pursuant to the Business Combination Agreement, the Company will migrate to and be continued as a company in British Columbia, Canada (the “SOAC Continuance”). Following the SOAC Continuance, pursuant to a plan of arrangement (the “Plan of Arrangement”) under the Business Corporations Act (British Columbia), (i) the Company will acquire all of the issued and outstanding shares in the capital of DeepGreen (the “DeepGreen Shares”) from DeepGreen shareholders in exchange for the Company’s common shares (as defined below) and Company Earnout Shares (as defined in Note 9) (the “Share Exchange”), (ii) DeepGreen will become a wholly-owned subsidiary of the Company, and (iii) DeepGreen and NewCo Sub will amalgamate to continue as one unlimited liability company, in each case, on the terms and subject to the conditions set forth in the Business Combination Agreement and the Plan of Arrangement and in accordance with the provisions of applicable law.

Concurrently with the execution of the Business Combination Agreement, the Company entered into subscription agreements (the “Subscription Agreements”) with certain institutional and accredited investors, pursuant to which such investors agreed to subscribe for and purchase, and the Company agreed to issue and sell to such investors, substantially concurrently with the Closing (as defined in the Business Combination Agreement), an aggregate of 33,030,000 shares of SOAC Ordinary shares for $10.00 per share, for aggregate gross proceeds of $330,300,000 (the “PIPE Financing”). The closing of the PIPE Financing is contingent upon, among other things, the substantially concurrent consummation of the Business Combination. The Subscription Agreements provide that the Company will grant the investors in the PIPE Financing certain customary registration rights. The PIPE Financing is contingent upon, among other things, the substantially concurrent closing of the Business Combination. See Note 9.

Going Concern Consideration

As of December 31, 2020, the Company had approximately $1.3 million in cash and a working capital deficit of approximately $372,000.

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses.

The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through November 8, 2021. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Basis of Presentation

The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for financial information and pursuant to the rules and regulations of the SEC.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with other public companies difficult or impossible because of the potential differences in accounting standards used.

Restatement of Previously Issued Financial Statements

12 Months Ended

Dec. 31, 2020

Condensed Financial Information Disclosure [Abstract]

Restatement of Previously Issued Financial Statements

Note 2 — Restatement of Previously Issued Financial Statements

On April 12, 2021, the Staff of the SEC issued a statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies.” In the statement, the SEC Staff, among other things, highlighted potential accounting implications of certain terms that are ordinary in warrants issued in connection with the initial public offerings of special purpose acquisition companies such as the Company. As a result of the Staff statement and in light of evolving views as to certain provisions ordinarily included in warrants issued by special purpose acquisition companies, the Company’s management re-evaluated the accounting for our Warrants under ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and concluded that they do not meet the criteria to be classified in shareholders’ equity. Since the Warrants meet the definition of a derivative under ASC 815-40, the Company has restated the financial statements to classify the Warrants as liabilities on the balance sheet at fair value, with subsequent changes in their respective fair values recognized in the statement of operations at each reporting date.

The Company’s prior accounting treatment for the Warrants was equity classification rather than as derivative liabilities. Accounting for the Warrants as liabilities pursuant to ASC 815-40 requires that the Company re-measure the Warrants to their fair value each reporting period and record the changes in such value in the statement of operations. Accordingly, the Company has restated the value and classification of the Warrants in our financial statements included herein (“Restatement”).

In April 2021, the Company concluded that, because of a misapplication of the accounting guidance related to its warrants issued in connection with its initial public offering (“Public Warrants”), as well as warrants issued in a private sale simultaneous to the initial public offering (“Private Placement Warrants”) that the Company issued in May 2020, the Company’s previously issued financial statements as of May 8, 2020, as of and for the year ended December 31, 2020 as well as the interim periods ended June 30, 2020 and September 30, 2020 (the “Affected Periods”) should no longer be relied upon. As such, the Company is restating its financial statements for the Affected Periods in this Annual Report. The following summarizes the effect of the Restatement on each financial statement line item for each period presented herein.

BALANCE SHEETS

		May 8, 2020			June 30, 2020			September 30, 2020			December 31, 2020
Warrant liability	As Previously Reported		-			-			-			-
	Adjustments		24,200,000			23,030,000			45,050,000			56,930,000
	As Restated		24,200,000			23,030,000			45,050,000			56,930,000

Total Liabilities	As Previously Reported		11,299,788			10,753,271			11,443,090			12,381,002
	Adjustments		24,200,000			23,030,000			45,050,000			56,930,000
	As Restated		35,499,788			33,783,271			56,493,090			69,311,002

Class A ordinary shares subject to possible redemption	As Previously Reported		287,041,190			286,786,990			285,557,170			284,197,210
	Adjustments		(24,214,650	)		(23,030,000	)		(45,050,000	)		(56,930,000	)
	As Restated		262,826,540			263,756,990			240,507,170			227,267,210

Class A ordinary shares subject to possible redemption, shares outstanding	As Previously Reported		28,704,119			28,678,699			28,555,717			28,419,721
	Adjustments		(2,421,465	)		(2,303,000	)		(4,505,000	)		(5,693,000	)
	As Restated		26,282,654			26,375,699			24,050,717			22,726,721

Class A ordinary shares	As Previously Reported		130			132			144			158
	Adjustments		242			230			451			569
	As Restated		372			362			595			727

Class A ordinary shares, shares outstanding	As Previously Reported		1,295,881			1,321,301			1,444,283			1,580,279
	Adjustments		2,421,465			2,303,000			4,505,000			5,693,000
	As Restated		3,717,346			3,624,301			5,949,283			7,273,279

Additional paid-in capital	As Previously Reported		5,113,134			5,352,792			6,582,601			7,942,547
	Adjustments		877,413			(292,578	)		21,727,203			33,607,078
	As Restated		5,990,547			5,060,214			28,309,804			41,549,625

Accumulated deficit	As Previously Reported		(114,123	)		(353,668	)		(1,583,490	)		(2,943,447	)
	Adjustments		(877,647	)		292,353			(21,727,647	)		(33,607,647	)
	As Restated		(991,770	)		(61,315	)		(23,311,137	)		(36,551,094	)

Total Shareholders’ equity	As Previously Reported		5,000,004			5,000,006			5,000,005			5,000,008
	Adjustments		(2	)		1			-			-
	As Restated		5,000,002			5,000,007			5,000,005			5,000,008

STATEMENTS OF OPERATIONS - YTD

		Six Months Ended June 30, 2020			Nine Months Ended September 30, 2020			Year Ended December 31, 2020
Change in fair value of the warrant liability	As Previously Reported		-			-			-
	Adjustments		1,170,000			(20,850,000	)		(32,730,000	)
	As Restated		1,170,000			(20,850,000	)		(32,730,000	)

Offering costs allocated to derivative warrant liabilities	As Previously Reported		-			-			-
	Adjustments		(877,647	)		(877,647	)		(877,647	)
	As Restated		(877,647	)		(877,647	)		(877,647	)

Net loss	As Previously Reported		(344,629	)		(1,574,451	)		(2,934,408	)
	Adjustments		292,353			(21,727,647	)		(33,607,647	)
	As Restated		(52,276	)		(23,302,098	)		(36,542,055	)

Weighted average shares outstanding subject to possible redemption, basic and diluted	As Previously Reported		N/A			N/A			28,635,732
	Adjustments		26,284,377			26,325,998			(3,194,817	)
	As Restated		26,284,377			26,325,998			25,440,915

Basic and diluted net income per share, shares subject to redemption	As Previously Reported		N/A			N/A		$	0.00
	Adjustments	$	0.00		$	0.00		$	0.00
	As Restated	$	0.00		$	0.00		$	0.00

Weighted average ordinary shares outstanding, basic and diluted	As Previously Reported		8,675,841			8,724,681			8,387,147
	Adjustments		(73,403	)		732,999			2,077,504
	As Restated		8,602,438			9,457,680			10,464,651

Basic and diluted net loss per share, Non-redeemable shares	As Previously Reported	$	(0.04	)	$	(0.19	)	$	(0.36	)
	Adjustments	$	0.03		$	(2.28	)	$	(3.14	)
	As Restated	$	(0.01	)	$	(2.47	)	$	(3.50	)

STATEMENTS OF OPERATIONS - THREE MONTHS ENDED

		Three Months Ended June 30, 2020			Three Months Ended September 30, 2020
Change in fair value of the warrant liability	As Previously Reported		-			-
	Adjustments		1,170,000			(22,020,000	)
	As Restated		1,170,000			(22,020,000	)

Offering costs allocated to derivative warrant liabilities	As Previously Reported		-			-
	Adjustments		(877,647	)		-
	As Restated		(877,647	)		-

Net income (loss)	As Previously Reported		(285,630	)		(1,229,822	)
	Adjustments		292,353			(22,020,000	)
	As Restated		6,723			(23,249,822	)

Weighted average shares outstanding subject to possible redemption, basic and diluted	As Previously Reported		N/A			N/A
	Adjustments		26,284,377			26,325,998
	As Restated		26,284,377			26,325,998

Basic and diluted net income per share, shares subject to redemption	As Previously Reported		N/A			N/A
	Adjustments	$	0.00		$	0.00
	As Restated	$	0.00		$	0.00

Weighted average ordinary shares outstanding, basic and diluted	As Previously Reported		8,726,681			8,821,301
	Adjustments		978,194			2,344,174
	As Restated		9,704,875			11,165,475

Basic and diluted net loss per share, Non-redeemable shares	As Previously Reported	$	(0.04	)	$	(0.14	)
	Adjustments	$	0.04		$	(1.94	)
	As Restated	$	(0.00	)	$	(2.08	)

STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

		June 30, 2020			September 30, 2020			December 31, 2020
Class A ordinary shares	As Previously Reported		132			144			158
	Adjustments		230			451			569
	As Restated		362			595			727

Additional Paid in Capital	As Previously Reported		5,352,793			6,582,601			7,942,547
	Adjustments		(292,579	)		21,727,203			33,607,078
	As Restated		5,060,214			28,309,804			41,549,625

Accumulated Deficit	As Previously Reported		(353,668	)		(1,583,490	)		(2,943,447	)
	Adjustments		292,353			(21,727,647	)		(33,607,647	)
	As Restated		(61,315	)		(23,311,137	)		(36,551,094	)

Total Shareholders’ Equity	As Previously Reported		5,000,006			5,000,005			5,000,008
	Adjustments		1			-			-
	As Restated		5,000,007			5,000,005			5,000,008

STATEMENTS OF CASH FLOWS

		Six Months Ended June 30, 2020			Nine Months Ended September 30, 2020			Year Ended December 31, 2020
Net loss	As Previously Reported		(344,629	)		(1,574,451	)		(2,934,408	)
	Adjustments		292,353			(21,727,647	)		(33,607,647	)
	As Restated		(52,276	)		(23,302,098	)		(36,542,055	)

Change in fair value of warrant liability	As Previously Reported		-			-			-
	Adjustments		(1,170,000	)		20,850,000			32,730,000
	As Restated		(1,170,000	)		20,850,000			32,730,000

Offering costs allocated to derivative warrant liabilities	As Previously Reported		-			-			-
	Adjustments		877,647			877,647			877,647
	As Restated		877,647			877,647			877,647

Initial value of Class A ordinary shares subject to possible redemption	As Previously Reported		287,041,190			287,041,190			287,041,190
	Adjustments		(24,214,650	)		(24,214,650	)		(24,214,650	)
	As Restated		262,826,540			262,826,540			262,826,540

Change in value of Class A ordinary shares subject to possible redemption	As Previously Reported		(254,200	)		(1,229,820	)		(2,843,980	)
	Adjustments		1,184,650			(22,020,000	)		(32,715,350	)
	As Restated		930,450			(23,249,820	)		(35,559,330	)

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 3 — Summary of Significant Accounting Policies

Use of Estimates

The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000 and investments held in Trust Account. The Company has not experienced losses on these accounts.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2020 and 2019, respectively.

Investments Held in Trust Account

The Company’s portfolio of marketable securities is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act. Upon the closing of the Initial Public Offering and the Private Placement, $300 million was placed in the Trust Account and invested in money market funds that invest in U.S. government securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in net gain on investments held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Fair Value Measurement

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

●

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

●

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

●

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Offering Costs Associated with the Initial Public Offering

The Company complies with the requirements of ASC 340-10-S99 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist of legal, accounting, underwriting fees and other costs that were directly related to the Initial Public Offering. Upon the completion of the Initial Public Offering on May 8, 2020, the offering costs were allocated to the separable financial instruments based on their relative fair value compared to the proceeds received, with $877,647 being expensed on fair value of warrant liabilities relative to Initial Public Offering proceeds.

Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

The Company issued 15,000,000 warrants as part of the units offered in its Initial Public Offering and, simultaneously with the closing of Initial Public Offering, the Company issued in a private placement an aggregate of 9,500,000 private placement warrants. The Company accounts for the Warrants in accordance with the guidance contained in ASC 815-40-15-7D and 7F under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of the Public Warrants was initially measured using a Modified Black Scholes Option Pricing Model and has subsequently been estimated using the Public Warrants’ quoted market price. The Private Placement Warrants are valued using a Modified Black Scholes Option Pricing Model.

Class A Ordinary Shares subject to possible redemption

Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as of December 31, 2020, 22,726,721 Class A ordinary shares subject to possible redemption were presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

Net Loss Per Ordinary Share

The Company applies the two-class method in calculating earnings per share. Net loss per share is computed by dividing net loss by the weighted-average number of ordinary shares outstanding during the periods. An aggregate of 22,726,721 and 0 Class A ordinary shares subject to possible redemption at December 31, 2020 and 2019, respectively has been excluded from the calculation of basic loss per ordinary share, since such shares, if redeemed, only participate in their pro rata share of the Trust earnings. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 24,500,000 Class A ordinary shares in the calculation of diluted loss per ordinary share, since the exercise of the warrants are contingent upon the occurrence of future events. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods presented.

Reconciliation of Net Loss per Ordinary Share

The Company’s net loss is adjusted for the portion of income (loss) that is attributable to ordinary shares subject to redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per ordinary share is calculated as follows:

	For the Year Ended December 31, 2020			For the Period from December 18, 2019 (inception) to December 31, 2019
Class A Ordinary Shares subject to possible redemption
Numerator: Earnings allocable to Ordinary Shares subject to possible redemption
Income from investments held in Trust Account	$	65,492		$	-
Less: Company’s portion available to be withdrawn to pay taxes		-			-
Net income attributable	$	65,492		$	-
Denominator: Weighted average Class A ordinary shares subject to possible redemption
Weighted average shares outstanding of shares subject to redemption, basic and diluted		25,440,915			-
Basic and diluted net income per share, shares subject to redemption	$	-		$	-

Non-Redeemable Ordinary Shares
Numerator: Net Loss minus Net Earnings attributable to redeemable shares
Net loss	$	(36,542,055	)	$	(9,039	)
Less: Income attributable to Class A ordinary shares subject to possible redemption		65,492			-
Non-redeemable net loss	$	(36,607,546	)	$	(9,039	)
Denominator: weighted average Non-redeemable ordinary shares
Weighted average ordinary shares outstanding, basic and diluted		10,464,651			7,500,000
Basic and diluted net loss per share, Non-redeemable shares	$	(3.50	)	$	(0.00	)

Income Taxes

FASB ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2020 and December 31, 2019. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2020 and December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

12 Months Ended

Dec. 31, 2020

Initial Public Offering [Abstract]

Initial Public Offering

Note 4 — Initial Public Offering

On May 8, 2020, the Company consummated its Initial Public Offering of 30,000,000 Units at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.4 million, inclusive of $10.5 million in deferred underwriting commissions. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8).

Related Party Transactions

12 Months Ended

Dec. 31, 2020

Related Party Transactions

Note 5 — Related Party Transactions

Founder Shares

On December 31, 2019, the Sponsor purchased 8,625,000 shares (the “Founder Shares”) of the Company’s Class B ordinary shares, par value $0.0001 for an aggregate price of $25,000. In March 2020, the Sponsor transferred 30,000 Founder Shares to each of the Company’s independent directors. The Founder Shares will automatically convert into Class A ordinary shares at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions, as described in Note 9. The Sponsor had agreed to forfeit up to 1,125,000 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriter so that the Founder Shares will represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. The over-allotment option expired in June 2020; thus, these Founder Shares were forfeited accordingly.

The Initial Shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.

Private Placement Warrants

Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 9,500,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant to the Sponsor, generating gross proceeds of $9.5 million. Each Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share.

A portion of the proceeds from the sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

Related Party Loans

On December 31, 2019, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. The Company borrowed approximately $163,000 under the Note and fully repaid this amount on May 8, 2020.

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of December 31, 2020, the Company had no borrowings under the Working Capital Loans.

Administrative Support Agreement

The Company entered into an agreement, commencing on May 8, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to reimburse the Sponsor a total of $10,000 per month for office space, secretarial and administrative services. The Company incurred and paid $80,000 and $0 in expenses in connection with such services and recorded in general and administrative expenses in the statements of operations for year ended December 31, 2020 and for the period December 18, 2019 (inception) to December 31, 2019, respectively.

Commitments & Contingencies

12 Months Ended

Dec. 31, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments & Contingencies

Note 6 — Commitments and Contingencies

Registration and Shareholder Rights

The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to Class A ordinary shares) pursuant to a registration and shareholder rights agreement. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriter a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit, less the underwriting discounts and commissions. The over-allotment option expired in June 2020.

The underwriter was entitled to an underwriting discount of $0.20 per unit, or $6.0 million in the aggregate paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $10.5 million in the aggregate will be payable to the underwriter for deferred underwriting commissions. The deferred underwriting commissions will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Consulting Agreement

The Company is receiving consulting services in connection with identification of potential targets for a Business Combination and due diligence on such targets. As compensation for such services, the Company paid a nonrefundable fixed fee of $350,000 and agreed to pay the consulting firm $2,650,000 solely in the event that the Company completes a Business Combination. The consulting agreement may be terminated early by either party to the agreement provided that the Company pays a termination fee to the consulting firm determined based on a monthly increasing amount through November 2021. As of December 31, 2020, the termination fee is $1,115,800, which has been accrued and recognized in general and administrative expenses within the statements of operations.

Fair Value Measurements

12 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements

Note 7 — Fair Value Measurements

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

As of December 31, 2020 and 2019, the carrying values of cash, prepaid expenses, and accounts payable approximate their fair values due to the short-term nature of the instruments. As of December 31, 2020, the Company’s portfolio of investments held in Trust Account is comprised entirely of investments in money market funds that invest in U.S. government securities.

The Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in the fair value of the Warrants are recorded in the statement of operations each period.

The following table presents our fair value hierarchy for liabilities measured at fair value on a recurring basis for each reporting period:

December 31, 2020 (As Restated)	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Public Warrants	$	33,750,000	$	—	$	—	$	33,750,000
Private Placement Warrants		—		—		23,180,000		23,180,000
Total warrant liabilities	$	33,750,000	$	—	$	23,180,000	$	56,930,000

September 30, 2020 (As Restated)	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Public Warrants(1)	$	27,000,000	$	—	$	—	$	27,000,000
Private Placement Warrants		—		—		18,050,000		18,050,000
Total warrant liabilities	$	27,000,000	$	—	$	18,050,000	$	45,050,000

June 30, 2020 (As Restated)	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Public Warrants	$	14,100,000	$	—	$	—	$	14,100,000
Private Placement Warrants		—		—		8,930,000		8,930,000
Total warrant liabilities	$	14,100,000	$	—	$	8,930,000	$	23,030,000

May 8, 2020 (As Restated)	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Public Warrants	$	—	$	—	$	14,700,000	$	14,700,000
Private Placement Warrants		—		—		9,500,000		9,500,000
Total warrant liabilities	$	—	$	—	$	24,200,000	$	24,200,000

(1)

Due to the use of quoted prices in an active market (Level 1) to measure the fair value of the Public Warrants, subsequent to initial measurement, the Company had transfers out of Level 3 totaling $14,700,000 during the period May 8, 2020 through December 31, 2020.

The Private Placement Warrants were valued using a modified Black Scholes Model including inputs from a Monte Carlo simulation, which is considered to be a Level 3 fair value measurement. The Monte Carlo simulation’s primary unobservable input utilized in determining the fair value of the Warrants is the probability of consummation of the Business Combination. The probability assigned to the consummation of the Business Combination was 88% which was estimated based on the observed success rates of business combinations for special purpose acquisition companies.

The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:

	As of May 8, 2020 (As Restated)			As of June 30, 2020 (As Restated)			As of September 30, 2020 (As Restated)			As of December 31, 2020 (As Restated)
Exercise price	$	11.50		$	11.50		$	11.50		$	11.50
IPO price		10.00			10.00			10.00			10.00
Implied stock price range (or underlying asset price at December 31, 2020)		9.51			9.70			10.20			10.76
Volatility		18.7	%		17.45	%		26.95	%		30.5	%
Term		5.91			5.75			5.50			5.25
Risk-free rate		0.44	%		37.00	%		33.00	%		0.40	%
Dividend yield		0.0	%		0.0	%		0.0	%		0.0	%

The following table presents the changes in the fair value of warrant liabilities:

	Private Placement			Public			Total Warrant Liabilities
Initial measurement on May 8, 2020 (As Restated)	$	9,500,000		$	14,700,000		$	24,200,000
Change in fair value of warrant liability		(570,000	)		(600,000	)		(1,170,000	)
Fair value, June 30, 2020 (As Restated)	$	8,930,000		$	14,100,000		$	23,030,000
Change in fair value of warrant liability		9,120,000			12,900,000			22,020,000
Fair value, September 30, 2020 (As Restated)	$	18,050,000		$	27,000,000		$	45,050,000
Change in fair value of warrant liability		5,130,000			6,750,000			11,880,000
Fair value, December 31, 2020 (As Restated)	$	23,180,000		$	33,750,000		$	56,930,000

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Shareholders' Equity

12 Months Ended

Dec. 31, 2020

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Note 8 — Shareholders’ Equity

Preference Shares

The Company is authorized to issue 1,000,000 preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2020 and December 31, 2019, there were no preference shares issued or outstanding.

Ordinary Shares

Class A Ordinary Shares — The Company is authorized to issue 300,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of December 31, 2020 and December 31, 2019, there were 30,000,000 and no Class A ordinary shares outstanding, including 28,419,721 and no Class A ordinary shares subject to possible redemption classified as temporary equity in the accompanying balance sheets, respectively.

Class B Ordinary Shares — The Company is authorized to issue 30,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of December 31, 2019, there were 8,625,000 Class B ordinary shares outstanding. Of these, an aggregate of up to 1,125,000 shares were subject to forfeiture to the Company by the Sponsor for no consideration to the extent that the underwriter’s over-allotment option was not exercised in full or in part, so that the Initial Shareholders will collectively own 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. The over-allotment option expired in June 2020; thus, an aggregate of 1,125,000 Class B ordinary shares was forfeited accordingly. As of December 31, 2020, there were 7,500,000 Class B ordinary shares outstanding.

Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders except as required by law.

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of Working Capital Loans. Any conversion of Class B ordinary shares will take effect as a compulsory redemption of Class B ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman Islands law. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.

Warrants

Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than 20 business days, after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60^th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share. If (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company and, (i) in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance, and (ii) without taking into account the transfer of Founder Shares or Private Placement Warrants (including if such transfer is effectuated as a surrender to us and subsequent reissuance by the Company) by the Sponsor in connection with such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20-trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price discussed below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

The Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants):

	●	in whole and not in part;

	●	at a price of $0.01 per warrant;

	●	upon a minimum of 30 days’ prior written notice of redemption, and

	●	if, and only if, the closing price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the Initial Shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Additionally, in no event will the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Subsequent Events

12 Months Ended

Dec. 31, 2020

Subsequent Events [Abstract]

Subsequent Events

Note 9 — Subsequent Events

Proposed Business Combination and Related Transactions

Pursuant to the Business Combination Agreement, the Company will migrate to and be continued as a company in British Columbia, Canada (the “SOAC Continuance”). Following the SOAC Continuance, pursuant to a plan of arrangement (the “Plan of Arrangement”) under the Business Corporations Act (British Columbia), (i) the Company will acquire all of the issued and outstanding shares in the capital of DeepGreen (the “DeepGreen Shares”) from DeepGreen shareholders in exchange for the Company’s common shares (as defined below) and Company Earnout Shares (as defined below) (the “Share Exchange”), (ii) DeepGreen will become a wholly-owned subsidiary of the Company, and (iii) DeepGreen and NewCo Sub will amalgamate to continue as one unlimited liability company, in each case, on the terms and subject to the conditions set forth in the Business Combination Agreement and the Plan of Arrangement and in accordance with the provisions of applicable law.

Each option to purchase common shares in the capital of the Company (the “DeepGreen Options”) will become an option to purchase SOAC Common Shares and Company Earnout Shares on the same terms and conditions (including applicable vesting, expiration and forfeiture provisions) that applied to the corresponding DeepGreen Options immediately prior to closing of the Business Combination.

The Proposed Business Combination is expected to close in the second quarter of 2021, following the receipt of the required approval by the Company’s shareholders and the fulfillment of other conditions.

The shareholders and the optionholders of DeepGreen will be entitled to receive, in exchange for their DeepGreen Shares or DeepGreen Options, as applicable, an aggregate of (i) will receive shares in the capital of the Company or comparable equity awards that are settled or are exercisable for shares in the capital of the Company, as applicable, based on an implied DeepGreen equity value of $2.25 billion after giving effect to the SOAC Continuance (the “SOAC Common Shares”), (ii) 5,000,000 Class A Special Shares, (iii) 10,000,000 Class B Special Shares, (iv) 10,000,000 Class C Special Shares, (v) 20,000,000 Class D Special Shares, (vi) 20,000,000 Class E Special Shares, (vii) 20,000,000 Class F Special Shares, (viii) 25,000,000 Class G Special Shares and (ix) 25,000,000 Class H Special Shares, in each case, in the capital of SOAC (collectively, the “Company Earnout Shares”), or, as applicable, options to purchase such SOAC Common Shares and Company Earnout Shares.

Concurrently with the execution of the Business Combination Agreement, the Company entered into subscription agreements (the “Subscription Agreements”) with certain institutional and accredited investors, pursuant to which such investors agreed to subscribe for and purchase, and the Company agreed to issue and sell to such investors, substantially concurrently with the Closing (as defined in the Business Combination Agreement), an aggregate of 33,030,000 shares of SOAC Common Shares for $10.00 per share, for aggregate gross proceeds of $330,300,000 (the “PIPE Financing”). The closing of the PIPE Financing is contingent upon, among other things, the substantially concurrent consummation of the Business Combination. The Subscription Agreements provide that the Company will grant the investors in the PIPE Financing certain customary registration rights. The PIPE Financing is contingent upon, among other things, the substantially concurrent closing of the Business Combination.

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements which have not previously been disclosed within the financial statements.

Accounting Policies, by Policy (Policies)

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Use of Estimates

Use of Estimates

Cash and Cash Equivalents

Cash and Cash Equivalents

Investments Held in Trust Account

Investments Held in Trust Account

Fair Value Measurement

Fair Value Measurement

●

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

●

Offering Costs Associated with the Initial Public Offering

Offering Costs Associated with the Initial Public Offering

Warrant Liabilities

Warrant Liabilities

Class A Ordinary Shares subject to possible redemption

Class A Ordinary Shares subject to possible redemption

Net Loss Per Ordinary Share

Net Loss Per Ordinary Share

Reconciliation of net loss per ordinary share

Reconciliation of Net Loss per Ordinary Share

	For the Year Ended December 31, 2020			For the Period from December 18, 2019 (inception) to December 31, 2019
Class A Ordinary Shares subject to possible redemption
Numerator: Earnings allocable to Ordinary Shares subject to possible redemption
Income from investments held in Trust Account	$	65,492		$	-
Less: Company’s portion available to be withdrawn to pay taxes		-			-
Net income attributable	$	65,492		$	-
Denominator: Weighted average Class A ordinary shares subject to possible redemption
Weighted average shares outstanding of shares subject to redemption, basic and diluted		25,440,915			-
Basic and diluted net income per share, shares subject to redemption	$	-		$	-

Non-Redeemable Ordinary Shares
Numerator: Net Loss minus Net Earnings attributable to redeemable shares
Net loss	$	(36,542,055	)	$	(9,039	)
Less: Income attributable to Class A ordinary shares subject to possible redemption		65,492			-
Non-redeemable net loss	$	(36,607,546	)	$	(9,039	)
Denominator: weighted average Non-redeemable ordinary shares
Weighted average ordinary shares outstanding, basic and diluted		10,464,651			7,500,000
Basic and diluted net loss per share, Non-redeemable shares	$	(3.50	)	$	(0.00	)

Income Taxes

Income Taxes

Recent Accounting Standards

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Restatement of Previously Issued Financial Statements (Tables)

12 Months Ended

Dec. 31, 2020

Condensed Financial Information Disclosure [Abstract]

Schedule of balance sheets

		May 8, 2020			June 30, 2020			September 30, 2020			December 31, 2020
Warrant liability	As Previously Reported		-			-			-			-
	Adjustments		24,200,000			23,030,000			45,050,000			56,930,000
	As Restated		24,200,000			23,030,000			45,050,000			56,930,000

Total Liabilities	As Previously Reported		11,299,788			10,753,271			11,443,090			12,381,002
	Adjustments		24,200,000			23,030,000			45,050,000			56,930,000
	As Restated		35,499,788			33,783,271			56,493,090			69,311,002

Class A ordinary shares subject to possible redemption	As Previously Reported		287,041,190			286,786,990			285,557,170			284,197,210
	Adjustments		(24,214,650	)		(23,030,000	)		(45,050,000	)		(56,930,000	)
	As Restated		262,826,540			263,756,990			240,507,170			227,267,210

Class A ordinary shares subject to possible redemption, shares outstanding	As Previously Reported		28,704,119			28,678,699			28,555,717			28,419,721
	Adjustments		(2,421,465	)		(2,303,000	)		(4,505,000	)		(5,693,000	)
	As Restated		26,282,654			26,375,699			24,050,717			22,726,721

Class A ordinary shares	As Previously Reported		130			132			144			158
	Adjustments		242			230			451			569
	As Restated		372			362			595			727

Class A ordinary shares, shares outstanding	As Previously Reported		1,295,881			1,321,301			1,444,283			1,580,279
	Adjustments		2,421,465			2,303,000			4,505,000			5,693,000
	As Restated		3,717,346			3,624,301			5,949,283			7,273,279

Additional paid-in capital	As Previously Reported		5,113,134			5,352,792			6,582,601			7,942,547
	Adjustments		877,413			(292,578	)		21,727,203			33,607,078
	As Restated		5,990,547			5,060,214			28,309,804			41,549,625

Accumulated deficit	As Previously Reported		(114,123	)		(353,668	)		(1,583,490	)		(2,943,447	)
	Adjustments		(877,647	)		292,353			(21,727,647	)		(33,607,647	)
	As Restated		(991,770	)		(61,315	)		(23,311,137	)		(36,551,094	)

Total Shareholders’ equity	As Previously Reported		5,000,004			5,000,006			5,000,005			5,000,008
	Adjustments		(2	)		1			-			-
	As Restated		5,000,002			5,000,007			5,000,005			5,000,008

Schedule of statements of operations

		Six Months Ended June 30, 2020			Nine Months Ended September 30, 2020			Year Ended December 31, 2020
Change in fair value of the warrant liability	As Previously Reported		-			-			-
	Adjustments		1,170,000			(20,850,000	)		(32,730,000	)
	As Restated		1,170,000			(20,850,000	)		(32,730,000	)

Offering costs allocated to derivative warrant liabilities	As Previously Reported		-			-			-
	Adjustments		(877,647	)		(877,647	)		(877,647	)
	As Restated		(877,647	)		(877,647	)		(877,647	)

Net loss	As Previously Reported		(344,629	)		(1,574,451	)		(2,934,408	)
	Adjustments		292,353			(21,727,647	)		(33,607,647	)
	As Restated		(52,276	)		(23,302,098	)		(36,542,055	)

Weighted average shares outstanding subject to possible redemption, basic and diluted	As Previously Reported		N/A			N/A			28,635,732
	Adjustments		26,284,377			26,325,998			(3,194,817	)
	As Restated		26,284,377			26,325,998			25,440,915

Basic and diluted net income per share, shares subject to redemption	As Previously Reported		N/A			N/A		$	0.00
	Adjustments	$	0.00		$	0.00		$	0.00
	As Restated	$	0.00		$	0.00		$	0.00

Weighted average ordinary shares outstanding, basic and diluted	As Previously Reported		8,675,841			8,724,681			8,387,147
	Adjustments		(73,403	)		732,999			2,077,504
	As Restated		8,602,438			9,457,680			10,464,651

Basic and diluted net loss per share, Non-redeemable shares	As Previously Reported	$	(0.04	)	$	(0.19	)	$	(0.36	)
	Adjustments	$	0.03		$	(2.28	)	$	(3.14	)
	As Restated	$	(0.01	)	$	(2.47	)	$	(3.50	)

		Three Months Ended June 30, 2020			Three Months Ended September 30, 2020
Change in fair value of the warrant liability	As Previously Reported		-			-
	Adjustments		1,170,000			(22,020,000	)
	As Restated		1,170,000			(22,020,000	)

Offering costs allocated to derivative warrant liabilities	As Previously Reported		-			-
	Adjustments		(877,647	)		-
	As Restated		(877,647	)		-

Net income (loss)	As Previously Reported		(285,630	)		(1,229,822	)
	Adjustments		292,353			(22,020,000	)
	As Restated		6,723			(23,249,822	)

Weighted average shares outstanding subject to possible redemption, basic and diluted	As Previously Reported		N/A			N/A
	Adjustments		26,284,377			26,325,998
	As Restated		26,284,377			26,325,998

Basic and diluted net income per share, shares subject to redemption	As Previously Reported		N/A			N/A
	Adjustments	$	0.00		$	0.00
	As Restated	$	0.00		$	0.00

Weighted average ordinary shares outstanding, basic and diluted	As Previously Reported		8,726,681			8,821,301
	Adjustments		978,194			2,344,174
	As Restated		9,704,875			11,165,475

Basic and diluted net loss per share, Non-redeemable shares	As Previously Reported	$	(0.04	)	$	(0.14	)
	Adjustments	$	0.04		$	(1.94	)
	As Restated	$	(0.00	)	$	(2.08	)

Schedule of statements of changes in stockholders’ equity

		June 30, 2020			September 30, 2020			December 31, 2020
Class A ordinary shares	As Previously Reported		132			144			158
	Adjustments		230			451			569
	As Restated		362			595			727

Additional Paid in Capital	As Previously Reported		5,352,793			6,582,601			7,942,547
	Adjustments		(292,579	)		21,727,203			33,607,078
	As Restated		5,060,214			28,309,804			41,549,625

Accumulated Deficit	As Previously Reported		(353,668	)		(1,583,490	)		(2,943,447	)
	Adjustments		292,353			(21,727,647	)		(33,607,647	)
	As Restated		(61,315	)		(23,311,137	)		(36,551,094	)

Total Shareholders’ Equity	As Previously Reported		5,000,006			5,000,005			5,000,008
	Adjustments		1			-			-
	As Restated		5,000,007			5,000,005			5,000,008

Schedule of statements of cash flows

		Six Months Ended June 30, 2020			Nine Months Ended September 30, 2020			Year Ended December 31, 2020
Net loss	As Previously Reported		(344,629	)		(1,574,451	)		(2,934,408	)
	Adjustments		292,353			(21,727,647	)		(33,607,647	)
	As Restated		(52,276	)		(23,302,098	)		(36,542,055	)

Change in fair value of warrant liability	As Previously Reported		-			-			-
	Adjustments		(1,170,000	)		20,850,000			32,730,000
	As Restated		(1,170,000	)		20,850,000			32,730,000

Offering costs allocated to derivative warrant liabilities	As Previously Reported		-			-			-
	Adjustments		877,647			877,647			877,647
	As Restated		877,647			877,647			877,647

Initial value of Class A ordinary shares subject to possible redemption	As Previously Reported		287,041,190			287,041,190			287,041,190
	Adjustments		(24,214,650	)		(24,214,650	)		(24,214,650	)
	As Restated		262,826,540			262,826,540			262,826,540

Change in value of Class A ordinary shares subject to possible redemption	As Previously Reported		(254,200	)		(1,229,820	)		(2,843,980	)
	Adjustments		1,184,650			(22,020,000	)		(32,715,350	)
	As Restated		930,450			(23,249,820	)		(35,559,330	)

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2020

Accounting Policies [Abstract]

Schedule of basic and diluted net income (loss) per common share

	For the Year Ended December 31, 2020			For the Period from December 18, 2019 (inception) to December 31, 2019
Class A Ordinary Shares subject to possible redemption
Numerator: Earnings allocable to Ordinary Shares subject to possible redemption
Income from investments held in Trust Account	$	65,492		$	-
Less: Company’s portion available to be withdrawn to pay taxes		-			-
Net income attributable	$	65,492		$	-
Denominator: Weighted average Class A ordinary shares subject to possible redemption
Weighted average shares outstanding of shares subject to redemption, basic and diluted		25,440,915			-
Basic and diluted net income per share, shares subject to redemption	$	-		$	-

Non-Redeemable Ordinary Shares
Numerator: Net Loss minus Net Earnings attributable to redeemable shares
Net loss	$	(36,542,055	)	$	(9,039	)
Less: Income attributable to Class A ordinary shares subject to possible redemption		65,492			-
Non-redeemable net loss	$	(36,607,546	)	$	(9,039	)
Denominator: weighted average Non-redeemable ordinary shares
Weighted average ordinary shares outstanding, basic and diluted		10,464,651			7,500,000
Basic and diluted net loss per share, Non-redeemable shares	$	(3.50	)	$	(0.00	)

Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Schedule of fair value hierarchy for liabilities measured at fair value on a recurring basis

December 31, 2020 (As Restated)	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Public Warrants	$	33,750,000	$	—	$	—	$	33,750,000
Private Placement Warrants		—		—		23,180,000		23,180,000
Total warrant liabilities	$	33,750,000	$	—	$	23,180,000	$	56,930,000

September 30, 2020 (As Restated)	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Public Warrants(1)	$	27,000,000	$	—	$	—	$	27,000,000
Private Placement Warrants		—		—		18,050,000		18,050,000
Total warrant liabilities	$	27,000,000	$	—	$	18,050,000	$	45,050,000

June 30, 2020 (As Restated)	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Public Warrants	$	14,100,000	$	—	$	—	$	14,100,000
Private Placement Warrants		—		—		8,930,000		8,930,000
Total warrant liabilities	$	14,100,000	$	—	$	8,930,000	$	23,030,000

May 8, 2020 (As Restated)	Level 1		Level 2		Level 3		Total
Warrant liabilities:
Public Warrants	$	—	$	—	$	14,700,000	$	14,700,000
Private Placement Warrants		—		—		9,500,000		9,500,000
Total warrant liabilities	$	—	$	—	$	24,200,000	$	24,200,000

(1)

Schedule of quantitative information regarding Level 3 fair value measurements inputs

	As of May 8, 2020 (As Restated)			As of June 30, 2020 (As Restated)			As of September 30, 2020 (As Restated)			As of December 31, 2020 (As Restated)
Exercise price	$	11.50		$	11.50		$	11.50		$	11.50
IPO price		10.00			10.00			10.00			10.00
Implied stock price range (or underlying asset price at December 31, 2020)		9.51			9.70			10.20			10.76
Volatility		18.7	%		17.45	%		26.95	%		30.5	%
Term		5.91			5.75			5.50			5.25
Risk-free rate		0.44	%		37.00	%		33.00	%		0.40	%
Dividend yield		0.0	%		0.0	%		0.0	%		0.0	%

Schedule of changes in the fair value of warrant liabilities

	Private Placement			Public			Total Warrant Liabilities
Initial measurement on May 8, 2020 (As Restated)	$	9,500,000		$	14,700,000		$	24,200,000
Change in fair value of warrant liability		(570,000	)		(600,000	)		(1,170,000	)
Fair value, June 30, 2020 (As Restated)	$	8,930,000		$	14,100,000		$	23,030,000
Change in fair value of warrant liability		9,120,000			12,900,000			22,020,000
Fair value, September 30, 2020 (As Restated)	$	18,050,000		$	27,000,000		$	45,050,000
Change in fair value of warrant liability		5,130,000			6,750,000			11,880,000
Fair value, December 31, 2020 (As Restated)	$	23,180,000		$	33,750,000		$	56,930,000

Description of Organization and Business Operations (Details) - USD ($)			12 Months Ended
	May 08, 2020	Dec. 31, 2019	Dec. 31, 2020
Description of Organization and Business Operations (Details) [Line Items]
Gross proceeds from issuance offering	$ 300,000,000		$ 300,000,000
Deferred underwriting commissions	$ 10,500,000
Number of units issued in transaction (in Shares)	9,500,000
Closing initial public offering ,description			Upon the closing of the Initial Public Offering and the Private Placement, $300.0 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement were placed in a trust account (the “Trust Account”), located in the United States at JP Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.
Aggregate fair market value, description			The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination.
Percentage of outstanding voting securities			50.00%
Public shareholders, description			The Company will provide the holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001 per share sold in the Initial Public Offering (the “Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share).
Amount of tangible assets			$ 5,000,001
Redeeming shares, percentage			15.00%
Percentage of redemption of company's outstanding public shares			100.00%
Description of business combination within the combination period			If the Company is unable to complete a Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay for its tax obligations, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
Price per shares (in Dollars per share)			$ 10.00
Shares, Issued (in Shares)			33,030,000
Shares Issued, Price Per Share (in Dollars per share)			$ 10.00
Debt Instrument, Face Amount			$ 330,300,000
Cash			1,300,000
working capital deficit			$ 372,000
Initial Public Offering [Member]
Description of Organization and Business Operations (Details) [Line Items]
Consummated Initial public Offering, shares (in Shares)	30,000,000
Public shares per unit (in Dollars per share)	$ 10.00
Gross proceeds from issuance offering	$ 300,000,000
Offering costs	17,400,000
Deferred underwriting commissions	$ 10,500,000
Number of units issued in transaction (in Shares)	30,000,000
Shares, Issued (in Shares)			4,500,000
Private Placement [Member]
Description of Organization and Business Operations (Details) [Line Items]
Gross proceeds from issuance offering	$ 9,500,000
Public shares per unit (in Dollars per share)	$ 1.00

Restatement of Previously Issued Financial Statements (Details) - Schedule of balance sheets - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	May 08, 2020
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant liability
Total Liabilities	12,381,002	11,443,090	10,753,271	11,299,788
Class A ordinary shares subject to possible redemption	$ 284,197,210	$ 285,557,170	$ 286,786,990	$ 287,041,190
Class A ordinary shares subject to possible redemption, shares outstanding (in Shares)	28,419,721	28,555,717	28,678,699	28,704,119
Class A ordinary shares (in Shares)	158	144	132	130
Class A ordinary shares, shares outstanding (in Shares)	1,580,279	1,444,283	1,321,301	1,295,881
Additional paid-in capital	$ 7,942,547	$ 6,582,601	$ 5,352,792	$ 5,113,134
Accumulated deficit	(2,943,447)	(1,583,490)	(353,668)	(114,123)
Total Shareholders’ equity	5,000,008	5,000,005	5,000,006	5,000,004
Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant liability	56,930,000	45,050,000	23,030,000	24,200,000
Total Liabilities	56,930,000	45,050,000	23,030,000	24,200,000
Class A ordinary shares subject to possible redemption	$ (56,930,000)	$ (45,050,000)	$ (23,030,000)	$ (24,214,650)
Class A ordinary shares subject to possible redemption, shares outstanding (in Shares)	(5,693,000)	(4,505,000)	(2,303,000)	(2,421,465)
Class A ordinary shares (in Shares)	569	451	230	242
Class A ordinary shares, shares outstanding (in Shares)	5,693,000	4,505,000	2,303,000	2,421,465
Additional paid-in capital	$ 33,607,078	$ 21,727,203	$ (292,578)	$ 877,413
Accumulated deficit	(33,607,647)	(21,727,647)	292,353	(877,647)
Total Shareholders’ equity			1	(2)
As Revised [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant liability	56,930,000	45,050,000	23,030,000	24,200,000
Total Liabilities	69,311,002	56,493,090	33,783,271	35,499,788
Class A ordinary shares subject to possible redemption	$ 227,267,210	$ 240,507,170	$ 263,756,990	$ 262,826,540
Class A ordinary shares subject to possible redemption, shares outstanding (in Shares)	22,726,721	24,050,717	26,375,699	26,282,654
Class A ordinary shares (in Shares)	727	595	362	372
Class A ordinary shares, shares outstanding (in Shares)	7,273,279	5,949,283	3,624,301	3,717,346
Additional paid-in capital	$ 41,549,625	$ 28,309,804	$ 5,060,214	$ 5,990,547
Accumulated deficit	(36,551,094)	(23,311,137)	(61,315)	(991,770)
Total Shareholders’ equity	$ 5,000,008	$ 5,000,005	$ 5,000,007	$ 5,000,002

Restatement of Previously Issued Financial Statements (Details) - Schedule of statements of operations - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
As Previously Reported [Member]
Condensed Income Statements, Captions [Line Items]
Change in fair value of the warrant liability
Offering costs allocated to derivative warrant liabilities
Net income (loss)	$ (1,229,822)	$ (285,630)	$ (344,629)	$ (1,574,451)	$ (2,934,408)
Weighted average shares outstanding subject to possible redemption, basic and diluted (in Shares)					28,635,732
Basic and diluted net income per share, shares subject to redemption (in Dollars per share)					$ 0.00
Weighted average ordinary shares outstanding, basic and diluted (in Shares)	8,821,301	8,726,681	8,675,841	8,724,681	8,387,147
Basic and diluted net loss per share, Non-redeemable shares (in Dollars per share)	$ (0.14)	$ (0.04)	$ (0.04)	$ (0.19)	$ (0.36)
Adjustments [Member]
Condensed Income Statements, Captions [Line Items]
Change in fair value of the warrant liability	$ (22,020,000)	$ 1,170,000	$ 1,170,000	$ (20,850,000)	$ (32,730,000)
Offering costs allocated to derivative warrant liabilities		(877,647)	(877,647)	(877,647)	(877,647)
Net income (loss)	$ (22,020,000)	$ 292,353	$ 292,353	$ (21,727,647)	$ (33,607,647)
Weighted average shares outstanding subject to possible redemption, basic and diluted (in Shares)	26,325,998	26,284,377	26,284,377	26,325,998	(3,194,817)
Basic and diluted net income per share, shares subject to redemption (in Dollars per share)	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted average ordinary shares outstanding, basic and diluted (in Shares)	2,344,174	978,194	(73,403)	732,999	2,077,504
Basic and diluted net loss per share, Non-redeemable shares (in Dollars per share)	$ (1.94)	$ 0.04	$ 0.03	$ (2.28)	$ (3.14)
As Revised [Member]
Condensed Income Statements, Captions [Line Items]
Change in fair value of the warrant liability	$ (22,020,000)	$ 1,170,000	$ 1,170,000	$ (20,850,000)	$ (32,730,000)
Offering costs allocated to derivative warrant liabilities		(877,647)	(877,647)	(877,647)	(877,647)
Net income (loss)	$ (23,249,822)	$ 6,723	$ (52,276)	$ (23,302,098)	$ (36,542,055)
Weighted average shares outstanding subject to possible redemption, basic and diluted (in Shares)	26,325,998	26,284,377	26,284,377	26,325,998	25,440,915
Basic and diluted net income per share, shares subject to redemption (in Dollars per share)	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted average ordinary shares outstanding, basic and diluted (in Shares)	11,165,475	9,704,875	8,602,438	9,457,680	10,464,651
Basic and diluted net loss per share, Non-redeemable shares (in Dollars per share)	$ (2.08)	$ 0.00	$ (0.01)	$ (2.47)	$ (3.50)

Restatement of Previously Issued Financial Statements (Details) - Schedule of statements of changes in stockholders’ equity - USD ($)	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	May 08, 2020
As Previously Reported [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of statements of changes in stockholders’ equity [Line Items]
Class A ordinary shares (in Shares)	158	144	132
Additional Paid in Capital	$ 7,942,547	$ 6,582,601	$ 5,352,792	$ 5,113,134
Accumulated Deficit	(2,943,447)	(1,583,490)	(353,668)	(114,123)
Total Shareholders' Equity	$ 5,000,008	$ 5,000,005	$ 5,000,006	5,000,004
Adjustments [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of statements of changes in stockholders’ equity [Line Items]
Class A ordinary shares (in Shares)	569	451	230
Additional Paid in Capital	$ 33,607,078	$ 21,727,203	$ (292,578)	877,413
Accumulated Deficit	(33,607,647)	(21,727,647)	292,353	(877,647)
Total Shareholders' Equity			$ 1	(2)
As Revised [Member]
Restatement of Previously Issued Financial Statements (Details) - Schedule of statements of changes in stockholders’ equity [Line Items]
Class A ordinary shares (in Shares)	727	595	362
Additional Paid in Capital	$ 41,549,625	$ 28,309,804	$ 5,060,214	5,990,547
Accumulated Deficit	(36,551,094)	(23,311,137)	(61,315)	(991,770)
Total Shareholders' Equity	$ 5,000,008	$ 5,000,005	$ 5,000,007	$ 5,000,002

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details

Restatement of Previously Issued Financial Statements (Details) - Schedule of statements of cash flows - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
As Previously Reported [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income (loss)	$ (1,229,822)	$ (285,630)	$ (344,629)	$ (1,574,451)	$ (2,934,408)
Change in fair value of warrant liability
Offering costs allocated to derivative warrant liabilities
Initial value of Class A ordinary shares subject to possible redemption			287,041,190	287,041,190	287,041,190
Change in value of Class A ordinary shares subject to possible redemption			(254,200)	(1,229,820)	(2,843,980)
Adjustments [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income (loss)	(22,020,000)	292,353	292,353	(21,727,647)	(33,607,647)
Change in fair value of warrant liability			(1,170,000)	20,850,000	32,730,000
Offering costs allocated to derivative warrant liabilities			877,647	877,647	877,647
Initial value of Class A ordinary shares subject to possible redemption			(24,214,650)	(24,214,650)	(24,214,650)
Change in value of Class A ordinary shares subject to possible redemption			1,184,650	(22,020,000)	(32,715,350)
As Revised [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income (loss)	$ (23,249,822)	$ 6,723	(52,276)	(23,302,098)	(36,542,055)
Change in fair value of warrant liability			(1,170,000)	20,850,000	32,730,000
Offering costs allocated to derivative warrant liabilities			877,647	877,647	877,647
Initial value of Class A ordinary shares subject to possible redemption			262,826,540	262,826,540	262,826,540
Change in value of Class A ordinary shares subject to possible redemption			$ 930,450	$ (23,249,820)	$ (35,559,330)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

Summary of Significant Accounting Policies (Details) - USD ($)		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020
Summary of Significant Accounting Policies (Details) [Line Items]
Federal depository insurance coverage (in Dollars)		$ 250,000
Money market fund (in Dollars)		300,000,000
Offering costs allocated to derivative warrant liabilities (in Dollars)		$ 877,647
Initial Public Offering [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Public warrants		15,000,000
Private Placement [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Public warrants		9,500,000
Class A ordinary shares [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Subject to possible redemption		22,726,721
Aggregate ordinary shares of subject to forfeiture	0	22,726,721
Diluted loss per share		24,500,000

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income (loss) per common share - USD ($)		12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020
Numerator: Earnings allocable to Ordinary Shares subject to possible redemption
Income from investments held in Trust Account		$ 65,492
Less: Company’s portion available to be withdrawn to pay taxes
Net income attributable		65,492
Numerator: Net Loss minus Net Earnings attributable to redeemable shares
Net loss	(9,039)	(36,542,055)
Less: Income attributable to Class A ordinary shares subject to possible redemption		65,492
Non-redeemable net loss	$ (9,039)	$ (36,607,546)
Denominator: weighted average Non-redeemable ordinary shares
Weighted average ordinary shares outstanding, basic and diluted (in Shares)	8,625,000	10,464,651
Basic and diluted net loss per share, Non-redeemable shares (in Dollars per share)	$ 0.00	$ (3.50)
Redeemable Shares [Member]
Denominator: Weighted average Class A ordinary shares subject to possible redemption
Weighted average shares outstanding of shares subject to redemption, basic and diluted (in Shares)		25,440,915
Basic and diluted net income per share, shares subject to redemption (in Dollars per share)
Nonredeemable Shares [Member]
Denominator: weighted average Non-redeemable ordinary shares
Weighted average ordinary shares outstanding, basic and diluted (in Shares)	7,500,000	10,464,651
Basic and diluted net loss per share, Non-redeemable shares (in Dollars per share)	$ 0.00	$ (3.50)

Initial Public Offering (Details) - USD ($)			12 Months Ended
Initial Public Offering (Details) - USD ($)	May 08, 2020	Dec. 31, 2019	Dec. 31, 2020
Initial Public Offering (Details) [Line Items]
Sale of Stock, Number of Shares Issued in Transaction (in Shares)	9,500,000
Initial public offering units	$ 300,000,000		$ 300,000,000
Offering costs	17,400,000
Deferred underwriting commissions	$ 10,500,000
Initial public offering, description	Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8).
Initial Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Sale of Stock, Number of Shares Issued in Transaction (in Shares)	30,000,000
Public shares per unit (in Dollars per share)	$ 10.00
Initial public offering units	$ 300,000,000
Deferred underwriting commissions	$ 10,500,000

Related Party Transactions (Details) - USD ($)			1 Months Ended	12 Months Ended
Related Party Transactions (Details) - USD ($)	May 08, 2020	Dec. 31, 2019	Mar. 31, 2020	Dec. 31, 2020
Related Party Transactions (Details) [Line Items]
Ordinary shares, par value (in Dollars per share)				$ 10.00
Percentage of issued and outstanding shares				20.00%
Private placement warrants, description				Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 9,500,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant to the Sponsor, generating gross proceeds of $9.5 million. Each Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share.
Warrants price per shares (in Shares)				1.00
Cover expenses		$ 300,000
Repaid amount	$ 163,000
Working capital loans				$ 1,500,000
Business combination price (in Dollars per share)				$ 1.00
Rental expenses	$ 10,000
General and administrative expenses		$ 80,000		$ 0
Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Sponsor purchased of ordinary shares (in Shares)		8,625,000
Aggregate price		$ 25,000
Sponsor transferred founder Shares (in Shares)			30,000
Sponsor [Member]
Related Party Transactions (Details) [Line Items]
Aggregate ordinary shares of subject to forfeiture (in Shares)				1,125,000
Percentage of issued and outstanding shares				20.00%
Class A Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Ordinary shares, par value (in Dollars per share)		$ 0.0001
Aggregate ordinary shares of subject to forfeiture (in Shares)		1,125,000		1,125,000
Class A Ordinary Shares [Member]
Related Party Transactions (Details) [Line Items]
Ordinary shares, par value (in Dollars per share)				$ 12.00
Aggregate ordinary shares of subject to forfeiture (in Shares)		0		22,726,721

Commitments & Contingencies (Details)	12 Months Ended
Commitments & Contingencies (Details)	Dec. 31, 2020 USD ($) $ / shares shares
Commitments & Contingencies (Details) [Line Items]
Additional purchase of shares (in Shares) \| shares	33,030,000
Underwriting agreement, description	The underwriter was entitled to an underwriting discount of $0.20 per unit, or $6.0 million in the aggregate paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $10.5 million in the aggregate will be payable to the underwriter for deferred underwriting commissions. The deferred underwriting commissions will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Services fee	$ 350,000
Consulting firm amount	2,650,000
Termination fee	$ 1,115,800
Initial Public Offering [Member]
Commitments & Contingencies (Details) [Line Items]
Additional purchase of shares (in Shares) \| shares	4,500,000
Unit price (in Dollars per share) \| $ / shares	$ 10.00

Fair Value Measurements (Details)	8 Months Ended
Fair Value Measurements (Details)	Dec. 31, 2020 USD ($)
Fair Value Measurements (Details) [Line Items]
Percentage of probability assigned to consummation of business combination	88.00%
Public Warrants [Member]
Fair Value Measurements (Details) [Line Items]
Total amount of transferred warrants	$ 14,700,000

Fair Value Measurements (Details) - Schedule of fair value hierarchy for liabilities measured at fair value on a recurring basis - USD ($)

Dec. 31, 2020

Sep. 30, 2020

Jun. 30, 2020

May 08, 2020

Warrant liabilities:

Public Warrants

$ 33,750,000

$ 27,000,000

^[1]

$ 14,100,000

$ 14,700,000

Private Placement Warrants

23,180,000

18,050,000

8,930,000

9,500,000

Total warrant liabilities

56,930,000

45,050,000

23,030,000

24,200,000

Level 1 [Member]

Warrant liabilities:

Public Warrants

33,750,000

27,000,000

^[1]

14,100,000

Private Placement Warrants

Total warrant liabilities

33,750,000

27,000,000

14,100,000

Level 2 [Member]

Warrant liabilities:

Public Warrants

^[1]

Private Placement Warrants

Total warrant liabilities

Level 3 [Member]

Warrant liabilities:

Public Warrants

^[1]

14,700,000

Private Placement Warrants

23,180,000

18,050,000

8,930,000

9,500,000

Total warrant liabilities

$ 23,180,000

$ 18,050,000

$ 8,930,000

$ 24,200,000

[1]	Due to the use of quoted prices in an active market (Level 1) to measure the fair value of the Public Warrants, subsequent to initial measurement, the Company had transfers out of Level 3 totaling $14,700,000 during the period May 8, 2020 through December 31, 2020.

Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements inputs - $ / shares		2 Months Ended	3 Months Ended
	May 08, 2020	Jun. 30, 2020	Dec. 31, 2020	Sep. 30, 2020
Schedule of quantitative information regarding Level 3 fair value measurements inputs [Abstract]
Exercise price	$ 11.50	$ 11.50	$ 11.50	$ 11.50
IPO price	10.00	10.00	10.00	10.00
Implied stock price range (or underlying asset price at December 31, 2020)	$ 9.51	$ 9.70	$ 10.76	$ 10.20
Volatility	18.70%	17.45%	30.50%	26.95%
Term	5 years 332 days	5 years 9 months	5 years 3 months	5 years 6 months
Risk-free rate	0.44%	37.00%	0.40%	33.00%
Dividend yield	0.00%	0.00%	0.00%	0.00%

Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities - USD ($)	2 Months Ended	3 Months Ended
	Jun. 30, 2020	Dec. 31, 2020	Sep. 30, 2020
Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]
Initial measurement	$ 24,200,000	$ 45,050,000	$ 23,030,000
Change in fair value of warrant liability	(1,170,000)	11,880,000	22,020,000
Fair value	23,030,000	56,930,000	45,050,000
Private Placement [Member]
Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]
Initial measurement	9,500,000	18,050,000	8,930,000
Change in fair value of warrant liability	(570,000)	5,130,000	9,120,000
Fair value	8,930,000	23,180,000	18,050,000
Public [Member]
Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities [Line Items]
Initial measurement	14,700,000	27,000,000	14,100,000
Change in fair value of warrant liability	(600,000)	6,750,000	12,900,000
Fair value	$ 14,100,000	$ 33,750,000	$ 27,000,000

Shareholders' Equity (Details) - $ / shares	12 Months Ended
Shareholders' Equity (Details) - $ / shares	Dec. 31, 2020	Dec. 31, 2019
Shareholders' Equity (Details) [Line Items]
Preferred stock, shares authorized	1,000,000	1,000,000
Percentage of issued and outstanding shares	20.00%
Converted percentage	20.00%
Description of warrant redemption	● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption, and ● if, and only if, the closing price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
Class A Ordinary Shares [Member]
Shareholders' Equity (Details) [Line Items]
Common stock, shares authorized	300,000,000	300,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, redemption shares	30,000,000
Excess Stock, Shares Outstanding	30,000,000	28,419,721
Common stock, shares outstanding	7,273,279	0
Aggregate ordinary shares of subject to forfeiture	22,726,721	0
Description of warrant redemption	Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share. If (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company and, (i) in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance, and (ii) without taking into account the transfer of Founder Shares or Private Placement Warrants (including if such transfer is effectuated as a surrender to us and subsequent reissuance by the Company) by the Sponsor in connection with such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20-trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price discussed below will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
Class B Ordinary Shares [Member]
Shareholders' Equity (Details) [Line Items]
Common stock, shares authorized	30,000,000	30,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares voting rights	Holders of Class B ordinary shares are entitled to one vote for each share.
Common stock, shares outstanding	7,500,000	8,625,000
Aggregate ordinary shares of subject to forfeiture	1,125,000	1,125,000

Subsequent Events (Details) - Subsequent Event [Member]	Mar. 04, 2021 USD ($) $ / shares shares
Subsequent Events (Details) [Line Items]
Shareholders, description	The shareholders and the optionholders of DeepGreen will be entitled to receive, in exchange for their DeepGreen Shares or DeepGreen Options, as applicable, an aggregate of (i) will receive shares in the capital of the Company or comparable equity awards that are settled or are exercisable for shares in the capital of the Company, as applicable, based on an implied DeepGreen equity value of $2.25 billion after giving effect to the SOAC Continuance (the “SOAC Common Shares”), (ii) 5,000,000 Class A Special Shares, (iii) 10,000,000 Class B Special Shares, (iv) 10,000,000 Class C Special Shares, (v) 20,000,000 Class D Special Shares, (vi) 20,000,000 Class E Special Shares, (vii) 20,000,000 Class F Special Shares, (viii) 25,000,000 Class G Special Shares and (ix) 25,000,000 Class H Special Shares, in each case, in the capital of SOAC (collectively, the “Company Earnout Shares”), or, as applicable, options to purchase such SOAC Common Shares and Company Earnout Shares.
Aggregate share \| shares	33,030,000
Common shares per share \| $ / shares	$ 10.00
Gross proceeds \| $	$ 330,300,000